Alnylam Pharmaceuticals (ALNY.MX) Q3 2013 Earnings

8AugConfirmed
Q1 1
Q3 2013
-27.2
-19.35
-11.5
-3.65

Details

Expected EPS
N/A
Actual EPS
-3.651042
Surprise EPS
-3.65
Surprise Percent
+∞%

Description

Alnylam Pharmaceuticals (ALNY.MX) has reported earnings of -3.651042 per share for Q3 2013.

0 Comments

Share your thoughts